Funding Rounds
Entia

Entia Series A (2023, $17M)

Entia

At-home blood testing platform for cancer patients.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $17.60M

Investors